Global Microbiome Therapeutics Market Research Report 2024(Status and Outlook)
Report Overview:
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The Global Microbiome Therapeutics Market Size was estimated at USD 128.89 million in 2023 and is projected to reach USD 894.07 million by 2029, exhibiting a CAGR of 38.10% during the forecast period.
This report provides a deep insight into the global Microbiome Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Microbiome Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Microbiome Therapeutics market in any manner.
Global Microbiome Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen
Market Segmentation (by Type)
Upper GIT
Lower GIT
Market Segmentation (by Application)
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Microbiome Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).
These microbes are generally not harmful to us; in fact they are essential for maintaining health. For example, they produce some vitamins that we do not have the genes to make, break down our food to extract nutrients we need to survive, teach our immune systems how to recognize dangerous invaders and even produce helpful anti-inflammatory compounds that fight off other disease-causing microbes.
An ever-growing number of studies have demonstrated that changes in the composition of our microbiomes correlate with numerous disease states, raising the possibility that manipulation of these communities could be used to treat disease.
The Global Microbiome Therapeutics Market Size was estimated at USD 128.89 million in 2023 and is projected to reach USD 894.07 million by 2029, exhibiting a CAGR of 38.10% during the forecast period.
This report provides a deep insight into the global Microbiome Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Microbiome Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Microbiome Therapeutics market in any manner.
Global Microbiome Therapeutics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
C3 Jian
Rebiotix
MicroBiome Therapeutics LLC
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Symbiotix Biotherapies
Osel
Metabogen
Market Segmentation (by Type)
Upper GIT
Lower GIT
Market Segmentation (by Application)
C. difficile Infection (CDI)
Inflammatory Bowel Disease (IBD)
Orphan Drug
Immuno-oncology
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Microbiome Therapeutics Market
- Overview of the regional outlook of the Microbiome Therapeutics Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Microbiome Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Microbiome Therapeutics
1.2 Key Market Segments
1.2.1 Microbiome Therapeutics Segment by Type
1.2.2 Microbiome Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MICROBIOME THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Microbiome Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Microbiome Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MICROBIOME THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Microbiome Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Microbiome Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Microbiome Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Microbiome Therapeutics Sales Sites, Area Served, Product Type
3.6 Microbiome Therapeutics Market Competitive Situation and Trends
3.6.1 Microbiome Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Microbiome Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MICROBIOME THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Microbiome Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MICROBIOME THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MICROBIOME THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Microbiome Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Microbiome Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Microbiome Therapeutics Price by Type (2019-2024)
7 MICROBIOME THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Microbiome Therapeutics Market Sales by Application (2019-2024)
7.3 Global Microbiome Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
8 MICROBIOME THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Microbiome Therapeutics Sales by Region
8.1.1 Global Microbiome Therapeutics Sales by Region
8.1.2 Global Microbiome Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Microbiome Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Microbiome Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Microbiome Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Microbiome Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Microbiome Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Seres Therapeutics
9.1.1 Seres Therapeutics Microbiome Therapeutics Basic Information
9.1.2 Seres Therapeutics Microbiome Therapeutics Product Overview
9.1.3 Seres Therapeutics Microbiome Therapeutics Product Market Performance
9.1.4 Seres Therapeutics Business Overview
9.1.5 Seres Therapeutics Microbiome Therapeutics SWOT Analysis
9.1.6 Seres Therapeutics Recent Developments
9.2 Assembly Biosciences
9.2.1 Assembly Biosciences Microbiome Therapeutics Basic Information
9.2.2 Assembly Biosciences Microbiome Therapeutics Product Overview
9.2.3 Assembly Biosciences Microbiome Therapeutics Product Market Performance
9.2.4 Assembly Biosciences Business Overview
9.2.5 Assembly Biosciences Microbiome Therapeutics SWOT Analysis
9.2.6 Assembly Biosciences Recent Developments
9.3 Synthetic Biologics
9.3.1 Synthetic Biologics Microbiome Therapeutics Basic Information
9.3.2 Synthetic Biologics Microbiome Therapeutics Product Overview
9.3.3 Synthetic Biologics Microbiome Therapeutics Product Market Performance
9.3.4 Synthetic Biologics Microbiome Therapeutics SWOT Analysis
9.3.5 Synthetic Biologics Business Overview
9.3.6 Synthetic Biologics Recent Developments
9.4 Interxon
9.4.1 Interxon Microbiome Therapeutics Basic Information
9.4.2 Interxon Microbiome Therapeutics Product Overview
9.4.3 Interxon Microbiome Therapeutics Product Market Performance
9.4.4 Interxon Business Overview
9.4.5 Interxon Recent Developments
9.5 PureTech
9.5.1 PureTech Microbiome Therapeutics Basic Information
9.5.2 PureTech Microbiome Therapeutics Product Overview
9.5.3 PureTech Microbiome Therapeutics Product Market Performance
9.5.4 PureTech Business Overview
9.5.5 PureTech Recent Developments
9.6 Synlogic
9.6.1 Synlogic Microbiome Therapeutics Basic Information
9.6.2 Synlogic Microbiome Therapeutics Product Overview
9.6.3 Synlogic Microbiome Therapeutics Product Market Performance
9.6.4 Synlogic Business Overview
9.6.5 Synlogic Recent Developments
9.7 Enterome BioScience
9.7.1 Enterome BioScience Microbiome Therapeutics Basic Information
9.7.2 Enterome BioScience Microbiome Therapeutics Product Overview
9.7.3 Enterome BioScience Microbiome Therapeutics Product Market Performance
9.7.4 Enterome BioScience Business Overview
9.7.5 Enterome BioScience Recent Developments
9.8 4D Pharma
9.8.1 4D Pharma Microbiome Therapeutics Basic Information
9.8.2 4D Pharma Microbiome Therapeutics Product Overview
9.8.3 4D Pharma Microbiome Therapeutics Product Market Performance
9.8.4 4D Pharma Business Overview
9.8.5 4D Pharma Recent Developments
9.9 Second Genome
9.9.1 Second Genome Microbiome Therapeutics Basic Information
9.9.2 Second Genome Microbiome Therapeutics Product Overview
9.9.3 Second Genome Microbiome Therapeutics Product Market Performance
9.9.4 Second Genome Business Overview
9.9.5 Second Genome Recent Developments
9.10 AOBiome
9.10.1 AOBiome Microbiome Therapeutics Basic Information
9.10.2 AOBiome Microbiome Therapeutics Product Overview
9.10.3 AOBiome Microbiome Therapeutics Product Market Performance
9.10.4 AOBiome Business Overview
9.10.5 AOBiome Recent Developments
9.11 C3 Jian
9.11.1 C3 Jian Microbiome Therapeutics Basic Information
9.11.2 C3 Jian Microbiome Therapeutics Product Overview
9.11.3 C3 Jian Microbiome Therapeutics Product Market Performance
9.11.4 C3 Jian Business Overview
9.11.5 C3 Jian Recent Developments
9.12 Rebiotix
9.12.1 Rebiotix Microbiome Therapeutics Basic Information
9.12.2 Rebiotix Microbiome Therapeutics Product Overview
9.12.3 Rebiotix Microbiome Therapeutics Product Market Performance
9.12.4 Rebiotix Business Overview
9.12.5 Rebiotix Recent Developments
9.13 MicroBiome Therapeutics LLC
9.13.1 MicroBiome Therapeutics LLC Microbiome Therapeutics Basic Information
9.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Overview
9.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Market Performance
9.13.4 MicroBiome Therapeutics LLC Business Overview
9.13.5 MicroBiome Therapeutics LLC Recent Developments
9.14 Metabiomics
9.14.1 Metabiomics Microbiome Therapeutics Basic Information
9.14.2 Metabiomics Microbiome Therapeutics Product Overview
9.14.3 Metabiomics Microbiome Therapeutics Product Market Performance
9.14.4 Metabiomics Business Overview
9.14.5 Metabiomics Recent Developments
9.15 Ritter Pharmaceuticals
9.15.1 Ritter Pharmaceuticals Microbiome Therapeutics Basic Information
9.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Overview
9.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Product Market Performance
9.15.4 Ritter Pharmaceuticals Business Overview
9.15.5 Ritter Pharmaceuticals Recent Developments
9.16 Symberix
9.16.1 Symberix Microbiome Therapeutics Basic Information
9.16.2 Symberix Microbiome Therapeutics Product Overview
9.16.3 Symberix Microbiome Therapeutics Product Market Performance
9.16.4 Symberix Business Overview
9.16.5 Symberix Recent Developments
9.17 OpenBiome
9.17.1 OpenBiome Microbiome Therapeutics Basic Information
9.17.2 OpenBiome Microbiome Therapeutics Product Overview
9.17.3 OpenBiome Microbiome Therapeutics Product Market Performance
9.17.4 OpenBiome Business Overview
9.17.5 OpenBiome Recent Developments
9.18 Azitra
9.18.1 Azitra Microbiome Therapeutics Basic Information
9.18.2 Azitra Microbiome Therapeutics Product Overview
9.18.3 Azitra Microbiome Therapeutics Product Market Performance
9.18.4 Azitra Business Overview
9.18.5 Azitra Recent Developments
9.19 Symbiotix Biotherapies
9.19.1 Symbiotix Biotherapies Microbiome Therapeutics Basic Information
9.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Overview
9.19.3 Symbiotix Biotherapies Microbiome Therapeutics Product Market Performance
9.19.4 Symbiotix Biotherapies Business Overview
9.19.5 Symbiotix Biotherapies Recent Developments
9.20 Osel
9.20.1 Osel Microbiome Therapeutics Basic Information
9.20.2 Osel Microbiome Therapeutics Product Overview
9.20.3 Osel Microbiome Therapeutics Product Market Performance
9.20.4 Osel Business Overview
9.20.5 Osel Recent Developments
9.21 Metabogen
9.21.1 Metabogen Microbiome Therapeutics Basic Information
9.21.2 Metabogen Microbiome Therapeutics Product Overview
9.21.3 Metabogen Microbiome Therapeutics Product Market Performance
9.21.4 Metabogen Business Overview
9.21.5 Metabogen Recent Developments
10 MICROBIOME THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Microbiome Therapeutics Market Size Forecast
10.2 Global Microbiome Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Microbiome Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Microbiome Therapeutics Market Size Forecast by Region
10.2.4 South America Microbiome Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Microbiome Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Microbiome Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Microbiome Therapeutics by Type (2025-2030)
11.1.2 Global Microbiome Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Microbiome Therapeutics by Type (2025-2030)
11.2 Global Microbiome Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Microbiome Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Microbiome Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Microbiome Therapeutics
1.2 Key Market Segments
1.2.1 Microbiome Therapeutics Segment by Type
1.2.2 Microbiome Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MICROBIOME THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Microbiome Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Microbiome Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MICROBIOME THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Global Microbiome Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Microbiome Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Microbiome Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Microbiome Therapeutics Sales Sites, Area Served, Product Type
3.6 Microbiome Therapeutics Market Competitive Situation and Trends
3.6.1 Microbiome Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Microbiome Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MICROBIOME THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Microbiome Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MICROBIOME THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MICROBIOME THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Microbiome Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Microbiome Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Microbiome Therapeutics Price by Type (2019-2024)
7 MICROBIOME THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Microbiome Therapeutics Market Sales by Application (2019-2024)
7.3 Global Microbiome Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
8 MICROBIOME THERAPEUTICS MARKET SEGMENTATION BY REGION
8.1 Global Microbiome Therapeutics Sales by Region
8.1.1 Global Microbiome Therapeutics Sales by Region
8.1.2 Global Microbiome Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Microbiome Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Microbiome Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Microbiome Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Microbiome Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Microbiome Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Seres Therapeutics
9.1.1 Seres Therapeutics Microbiome Therapeutics Basic Information
9.1.2 Seres Therapeutics Microbiome Therapeutics Product Overview
9.1.3 Seres Therapeutics Microbiome Therapeutics Product Market Performance
9.1.4 Seres Therapeutics Business Overview
9.1.5 Seres Therapeutics Microbiome Therapeutics SWOT Analysis
9.1.6 Seres Therapeutics Recent Developments
9.2 Assembly Biosciences
9.2.1 Assembly Biosciences Microbiome Therapeutics Basic Information
9.2.2 Assembly Biosciences Microbiome Therapeutics Product Overview
9.2.3 Assembly Biosciences Microbiome Therapeutics Product Market Performance
9.2.4 Assembly Biosciences Business Overview
9.2.5 Assembly Biosciences Microbiome Therapeutics SWOT Analysis
9.2.6 Assembly Biosciences Recent Developments
9.3 Synthetic Biologics
9.3.1 Synthetic Biologics Microbiome Therapeutics Basic Information
9.3.2 Synthetic Biologics Microbiome Therapeutics Product Overview
9.3.3 Synthetic Biologics Microbiome Therapeutics Product Market Performance
9.3.4 Synthetic Biologics Microbiome Therapeutics SWOT Analysis
9.3.5 Synthetic Biologics Business Overview
9.3.6 Synthetic Biologics Recent Developments
9.4 Interxon
9.4.1 Interxon Microbiome Therapeutics Basic Information
9.4.2 Interxon Microbiome Therapeutics Product Overview
9.4.3 Interxon Microbiome Therapeutics Product Market Performance
9.4.4 Interxon Business Overview
9.4.5 Interxon Recent Developments
9.5 PureTech
9.5.1 PureTech Microbiome Therapeutics Basic Information
9.5.2 PureTech Microbiome Therapeutics Product Overview
9.5.3 PureTech Microbiome Therapeutics Product Market Performance
9.5.4 PureTech Business Overview
9.5.5 PureTech Recent Developments
9.6 Synlogic
9.6.1 Synlogic Microbiome Therapeutics Basic Information
9.6.2 Synlogic Microbiome Therapeutics Product Overview
9.6.3 Synlogic Microbiome Therapeutics Product Market Performance
9.6.4 Synlogic Business Overview
9.6.5 Synlogic Recent Developments
9.7 Enterome BioScience
9.7.1 Enterome BioScience Microbiome Therapeutics Basic Information
9.7.2 Enterome BioScience Microbiome Therapeutics Product Overview
9.7.3 Enterome BioScience Microbiome Therapeutics Product Market Performance
9.7.4 Enterome BioScience Business Overview
9.7.5 Enterome BioScience Recent Developments
9.8 4D Pharma
9.8.1 4D Pharma Microbiome Therapeutics Basic Information
9.8.2 4D Pharma Microbiome Therapeutics Product Overview
9.8.3 4D Pharma Microbiome Therapeutics Product Market Performance
9.8.4 4D Pharma Business Overview
9.8.5 4D Pharma Recent Developments
9.9 Second Genome
9.9.1 Second Genome Microbiome Therapeutics Basic Information
9.9.2 Second Genome Microbiome Therapeutics Product Overview
9.9.3 Second Genome Microbiome Therapeutics Product Market Performance
9.9.4 Second Genome Business Overview
9.9.5 Second Genome Recent Developments
9.10 AOBiome
9.10.1 AOBiome Microbiome Therapeutics Basic Information
9.10.2 AOBiome Microbiome Therapeutics Product Overview
9.10.3 AOBiome Microbiome Therapeutics Product Market Performance
9.10.4 AOBiome Business Overview
9.10.5 AOBiome Recent Developments
9.11 C3 Jian
9.11.1 C3 Jian Microbiome Therapeutics Basic Information
9.11.2 C3 Jian Microbiome Therapeutics Product Overview
9.11.3 C3 Jian Microbiome Therapeutics Product Market Performance
9.11.4 C3 Jian Business Overview
9.11.5 C3 Jian Recent Developments
9.12 Rebiotix
9.12.1 Rebiotix Microbiome Therapeutics Basic Information
9.12.2 Rebiotix Microbiome Therapeutics Product Overview
9.12.3 Rebiotix Microbiome Therapeutics Product Market Performance
9.12.4 Rebiotix Business Overview
9.12.5 Rebiotix Recent Developments
9.13 MicroBiome Therapeutics LLC
9.13.1 MicroBiome Therapeutics LLC Microbiome Therapeutics Basic Information
9.13.2 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Overview
9.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Product Market Performance
9.13.4 MicroBiome Therapeutics LLC Business Overview
9.13.5 MicroBiome Therapeutics LLC Recent Developments
9.14 Metabiomics
9.14.1 Metabiomics Microbiome Therapeutics Basic Information
9.14.2 Metabiomics Microbiome Therapeutics Product Overview
9.14.3 Metabiomics Microbiome Therapeutics Product Market Performance
9.14.4 Metabiomics Business Overview
9.14.5 Metabiomics Recent Developments
9.15 Ritter Pharmaceuticals
9.15.1 Ritter Pharmaceuticals Microbiome Therapeutics Basic Information
9.15.2 Ritter Pharmaceuticals Microbiome Therapeutics Product Overview
9.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Product Market Performance
9.15.4 Ritter Pharmaceuticals Business Overview
9.15.5 Ritter Pharmaceuticals Recent Developments
9.16 Symberix
9.16.1 Symberix Microbiome Therapeutics Basic Information
9.16.2 Symberix Microbiome Therapeutics Product Overview
9.16.3 Symberix Microbiome Therapeutics Product Market Performance
9.16.4 Symberix Business Overview
9.16.5 Symberix Recent Developments
9.17 OpenBiome
9.17.1 OpenBiome Microbiome Therapeutics Basic Information
9.17.2 OpenBiome Microbiome Therapeutics Product Overview
9.17.3 OpenBiome Microbiome Therapeutics Product Market Performance
9.17.4 OpenBiome Business Overview
9.17.5 OpenBiome Recent Developments
9.18 Azitra
9.18.1 Azitra Microbiome Therapeutics Basic Information
9.18.2 Azitra Microbiome Therapeutics Product Overview
9.18.3 Azitra Microbiome Therapeutics Product Market Performance
9.18.4 Azitra Business Overview
9.18.5 Azitra Recent Developments
9.19 Symbiotix Biotherapies
9.19.1 Symbiotix Biotherapies Microbiome Therapeutics Basic Information
9.19.2 Symbiotix Biotherapies Microbiome Therapeutics Product Overview
9.19.3 Symbiotix Biotherapies Microbiome Therapeutics Product Market Performance
9.19.4 Symbiotix Biotherapies Business Overview
9.19.5 Symbiotix Biotherapies Recent Developments
9.20 Osel
9.20.1 Osel Microbiome Therapeutics Basic Information
9.20.2 Osel Microbiome Therapeutics Product Overview
9.20.3 Osel Microbiome Therapeutics Product Market Performance
9.20.4 Osel Business Overview
9.20.5 Osel Recent Developments
9.21 Metabogen
9.21.1 Metabogen Microbiome Therapeutics Basic Information
9.21.2 Metabogen Microbiome Therapeutics Product Overview
9.21.3 Metabogen Microbiome Therapeutics Product Market Performance
9.21.4 Metabogen Business Overview
9.21.5 Metabogen Recent Developments
10 MICROBIOME THERAPEUTICS MARKET FORECAST BY REGION
10.1 Global Microbiome Therapeutics Market Size Forecast
10.2 Global Microbiome Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Microbiome Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Microbiome Therapeutics Market Size Forecast by Region
10.2.4 South America Microbiome Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Microbiome Therapeutics by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Microbiome Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Microbiome Therapeutics by Type (2025-2030)
11.1.2 Global Microbiome Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Microbiome Therapeutics by Type (2025-2030)
11.2 Global Microbiome Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Microbiome Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Microbiome Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Microbiome Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Microbiome Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Microbiome Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Microbiome Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Microbiome Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2022)
Table 10. Global Market Microbiome Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Microbiome Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Microbiome Therapeutics Product Type
Table 13. Global Microbiome Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Microbiome Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Microbiome Therapeutics Market Challenges
Table 22. Global Microbiome Therapeutics Sales by Type (K Units)
Table 23. Global Microbiome Therapeutics Market Size by Type (M USD)
Table 24. Global Microbiome Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Microbiome Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Microbiome Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Microbiome Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Microbiome Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Microbiome Therapeutics Sales (K Units) by Application
Table 30. Global Microbiome Therapeutics Market Size by Application
Table 31. Global Microbiome Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Microbiome Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Microbiome Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Microbiome Therapeutics Market Share by Application (2019-2024)
Table 35. Global Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Microbiome Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Seres Therapeutics Microbiome Therapeutics Basic Information
Table 44. Seres Therapeutics Microbiome Therapeutics Product Overview
Table 45. Seres Therapeutics Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Seres Therapeutics Business Overview
Table 47. Seres Therapeutics Microbiome Therapeutics SWOT Analysis
Table 48. Seres Therapeutics Recent Developments
Table 49. Assembly Biosciences Microbiome Therapeutics Basic Information
Table 50. Assembly Biosciences Microbiome Therapeutics Product Overview
Table 51. Assembly Biosciences Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Assembly Biosciences Business Overview
Table 53. Assembly Biosciences Microbiome Therapeutics SWOT Analysis
Table 54. Assembly Biosciences Recent Developments
Table 55. Synthetic Biologics Microbiome Therapeutics Basic Information
Table 56. Synthetic Biologics Microbiome Therapeutics Product Overview
Table 57. Synthetic Biologics Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Synthetic Biologics Microbiome Therapeutics SWOT Analysis
Table 59. Synthetic Biologics Business Overview
Table 60. Synthetic Biologics Recent Developments
Table 61. Interxon Microbiome Therapeutics Basic Information
Table 62. Interxon Microbiome Therapeutics Product Overview
Table 63. Interxon Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Interxon Business Overview
Table 65. Interxon Recent Developments
Table 66. PureTech Microbiome Therapeutics Basic Information
Table 67. PureTech Microbiome Therapeutics Product Overview
Table 68. PureTech Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. PureTech Business Overview
Table 70. PureTech Recent Developments
Table 71. Synlogic Microbiome Therapeutics Basic Information
Table 72. Synlogic Microbiome Therapeutics Product Overview
Table 73. Synlogic Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Synlogic Business Overview
Table 75. Synlogic Recent Developments
Table 76. Enterome BioScience Microbiome Therapeutics Basic Information
Table 77. Enterome BioScience Microbiome Therapeutics Product Overview
Table 78. Enterome BioScience Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Enterome BioScience Business Overview
Table 80. Enterome BioScience Recent Developments
Table 81. 4D Pharma Microbiome Therapeutics Basic Information
Table 82. 4D Pharma Microbiome Therapeutics Product Overview
Table 83. 4D Pharma Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. 4D Pharma Business Overview
Table 85. 4D Pharma Recent Developments
Table 86. Second Genome Microbiome Therapeutics Basic Information
Table 87. Second Genome Microbiome Therapeutics Product Overview
Table 88. Second Genome Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Second Genome Business Overview
Table 90. Second Genome Recent Developments
Table 91. AOBiome Microbiome Therapeutics Basic Information
Table 92. AOBiome Microbiome Therapeutics Product Overview
Table 93. AOBiome Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AOBiome Business Overview
Table 95. AOBiome Recent Developments
Table 96. C3 Jian Microbiome Therapeutics Basic Information
Table 97. C3 Jian Microbiome Therapeutics Product Overview
Table 98. C3 Jian Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. C3 Jian Business Overview
Table 100. C3 Jian Recent Developments
Table 101. Rebiotix Microbiome Therapeutics Basic Information
Table 102. Rebiotix Microbiome Therapeutics Product Overview
Table 103. Rebiotix Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Rebiotix Business Overview
Table 105. Rebiotix Recent Developments
Table 106. MicroBiome Therapeutics LLC Microbiome Therapeutics Basic Information
Table 107. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Overview
Table 108. MicroBiome Therapeutics LLC Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. MicroBiome Therapeutics LLC Business Overview
Table 110. MicroBiome Therapeutics LLC Recent Developments
Table 111. Metabiomics Microbiome Therapeutics Basic Information
Table 112. Metabiomics Microbiome Therapeutics Product Overview
Table 113. Metabiomics Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Metabiomics Business Overview
Table 115. Metabiomics Recent Developments
Table 116. Ritter Pharmaceuticals Microbiome Therapeutics Basic Information
Table 117. Ritter Pharmaceuticals Microbiome Therapeutics Product Overview
Table 118. Ritter Pharmaceuticals Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Ritter Pharmaceuticals Business Overview
Table 120. Ritter Pharmaceuticals Recent Developments
Table 121. Symberix Microbiome Therapeutics Basic Information
Table 122. Symberix Microbiome Therapeutics Product Overview
Table 123. Symberix Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Symberix Business Overview
Table 125. Symberix Recent Developments
Table 126. OpenBiome Microbiome Therapeutics Basic Information
Table 127. OpenBiome Microbiome Therapeutics Product Overview
Table 128. OpenBiome Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. OpenBiome Business Overview
Table 130. OpenBiome Recent Developments
Table 131. Azitra Microbiome Therapeutics Basic Information
Table 132. Azitra Microbiome Therapeutics Product Overview
Table 133. Azitra Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Azitra Business Overview
Table 135. Azitra Recent Developments
Table 136. Symbiotix Biotherapies Microbiome Therapeutics Basic Information
Table 137. Symbiotix Biotherapies Microbiome Therapeutics Product Overview
Table 138. Symbiotix Biotherapies Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Symbiotix Biotherapies Business Overview
Table 140. Symbiotix Biotherapies Recent Developments
Table 141. Osel Microbiome Therapeutics Basic Information
Table 142. Osel Microbiome Therapeutics Product Overview
Table 143. Osel Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Osel Business Overview
Table 145. Osel Recent Developments
Table 146. Metabogen Microbiome Therapeutics Basic Information
Table 147. Metabogen Microbiome Therapeutics Product Overview
Table 148. Metabogen Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Metabogen Business Overview
Table 150. Metabogen Recent Developments
Table 151. Global Microbiome Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Microbiome Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Microbiome Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Microbiome Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Microbiome Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Microbiome Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Microbiome Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Microbiome Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Microbiome Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Microbiome Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Microbiome Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Microbiome Therapeutics Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Microbiome Therapeutics Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Microbiome Therapeutics Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Microbiome Therapeutics Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics as of 2022)
Table 10. Global Market Microbiome Therapeutics Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Microbiome Therapeutics Sales Sites and Area Served
Table 12. Manufacturers Microbiome Therapeutics Product Type
Table 13. Global Microbiome Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Microbiome Therapeutics
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Microbiome Therapeutics Market Challenges
Table 22. Global Microbiome Therapeutics Sales by Type (K Units)
Table 23. Global Microbiome Therapeutics Market Size by Type (M USD)
Table 24. Global Microbiome Therapeutics Sales (K Units) by Type (2019-2024)
Table 25. Global Microbiome Therapeutics Sales Market Share by Type (2019-2024)
Table 26. Global Microbiome Therapeutics Market Size (M USD) by Type (2019-2024)
Table 27. Global Microbiome Therapeutics Market Size Share by Type (2019-2024)
Table 28. Global Microbiome Therapeutics Price (USD/Unit) by Type (2019-2024)
Table 29. Global Microbiome Therapeutics Sales (K Units) by Application
Table 30. Global Microbiome Therapeutics Market Size by Application
Table 31. Global Microbiome Therapeutics Sales by Application (2019-2024) & (K Units)
Table 32. Global Microbiome Therapeutics Sales Market Share by Application (2019-2024)
Table 33. Global Microbiome Therapeutics Sales by Application (2019-2024) & (M USD)
Table 34. Global Microbiome Therapeutics Market Share by Application (2019-2024)
Table 35. Global Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
Table 36. Global Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 37. Global Microbiome Therapeutics Sales Market Share by Region (2019-2024)
Table 38. North America Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 39. Europe Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 41. South America Microbiome Therapeutics Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Microbiome Therapeutics Sales by Region (2019-2024) & (K Units)
Table 43. Seres Therapeutics Microbiome Therapeutics Basic Information
Table 44. Seres Therapeutics Microbiome Therapeutics Product Overview
Table 45. Seres Therapeutics Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Seres Therapeutics Business Overview
Table 47. Seres Therapeutics Microbiome Therapeutics SWOT Analysis
Table 48. Seres Therapeutics Recent Developments
Table 49. Assembly Biosciences Microbiome Therapeutics Basic Information
Table 50. Assembly Biosciences Microbiome Therapeutics Product Overview
Table 51. Assembly Biosciences Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Assembly Biosciences Business Overview
Table 53. Assembly Biosciences Microbiome Therapeutics SWOT Analysis
Table 54. Assembly Biosciences Recent Developments
Table 55. Synthetic Biologics Microbiome Therapeutics Basic Information
Table 56. Synthetic Biologics Microbiome Therapeutics Product Overview
Table 57. Synthetic Biologics Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Synthetic Biologics Microbiome Therapeutics SWOT Analysis
Table 59. Synthetic Biologics Business Overview
Table 60. Synthetic Biologics Recent Developments
Table 61. Interxon Microbiome Therapeutics Basic Information
Table 62. Interxon Microbiome Therapeutics Product Overview
Table 63. Interxon Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Interxon Business Overview
Table 65. Interxon Recent Developments
Table 66. PureTech Microbiome Therapeutics Basic Information
Table 67. PureTech Microbiome Therapeutics Product Overview
Table 68. PureTech Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. PureTech Business Overview
Table 70. PureTech Recent Developments
Table 71. Synlogic Microbiome Therapeutics Basic Information
Table 72. Synlogic Microbiome Therapeutics Product Overview
Table 73. Synlogic Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Synlogic Business Overview
Table 75. Synlogic Recent Developments
Table 76. Enterome BioScience Microbiome Therapeutics Basic Information
Table 77. Enterome BioScience Microbiome Therapeutics Product Overview
Table 78. Enterome BioScience Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Enterome BioScience Business Overview
Table 80. Enterome BioScience Recent Developments
Table 81. 4D Pharma Microbiome Therapeutics Basic Information
Table 82. 4D Pharma Microbiome Therapeutics Product Overview
Table 83. 4D Pharma Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. 4D Pharma Business Overview
Table 85. 4D Pharma Recent Developments
Table 86. Second Genome Microbiome Therapeutics Basic Information
Table 87. Second Genome Microbiome Therapeutics Product Overview
Table 88. Second Genome Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Second Genome Business Overview
Table 90. Second Genome Recent Developments
Table 91. AOBiome Microbiome Therapeutics Basic Information
Table 92. AOBiome Microbiome Therapeutics Product Overview
Table 93. AOBiome Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AOBiome Business Overview
Table 95. AOBiome Recent Developments
Table 96. C3 Jian Microbiome Therapeutics Basic Information
Table 97. C3 Jian Microbiome Therapeutics Product Overview
Table 98. C3 Jian Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. C3 Jian Business Overview
Table 100. C3 Jian Recent Developments
Table 101. Rebiotix Microbiome Therapeutics Basic Information
Table 102. Rebiotix Microbiome Therapeutics Product Overview
Table 103. Rebiotix Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Rebiotix Business Overview
Table 105. Rebiotix Recent Developments
Table 106. MicroBiome Therapeutics LLC Microbiome Therapeutics Basic Information
Table 107. MicroBiome Therapeutics LLC Microbiome Therapeutics Product Overview
Table 108. MicroBiome Therapeutics LLC Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. MicroBiome Therapeutics LLC Business Overview
Table 110. MicroBiome Therapeutics LLC Recent Developments
Table 111. Metabiomics Microbiome Therapeutics Basic Information
Table 112. Metabiomics Microbiome Therapeutics Product Overview
Table 113. Metabiomics Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Metabiomics Business Overview
Table 115. Metabiomics Recent Developments
Table 116. Ritter Pharmaceuticals Microbiome Therapeutics Basic Information
Table 117. Ritter Pharmaceuticals Microbiome Therapeutics Product Overview
Table 118. Ritter Pharmaceuticals Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Ritter Pharmaceuticals Business Overview
Table 120. Ritter Pharmaceuticals Recent Developments
Table 121. Symberix Microbiome Therapeutics Basic Information
Table 122. Symberix Microbiome Therapeutics Product Overview
Table 123. Symberix Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Symberix Business Overview
Table 125. Symberix Recent Developments
Table 126. OpenBiome Microbiome Therapeutics Basic Information
Table 127. OpenBiome Microbiome Therapeutics Product Overview
Table 128. OpenBiome Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. OpenBiome Business Overview
Table 130. OpenBiome Recent Developments
Table 131. Azitra Microbiome Therapeutics Basic Information
Table 132. Azitra Microbiome Therapeutics Product Overview
Table 133. Azitra Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Azitra Business Overview
Table 135. Azitra Recent Developments
Table 136. Symbiotix Biotherapies Microbiome Therapeutics Basic Information
Table 137. Symbiotix Biotherapies Microbiome Therapeutics Product Overview
Table 138. Symbiotix Biotherapies Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Symbiotix Biotherapies Business Overview
Table 140. Symbiotix Biotherapies Recent Developments
Table 141. Osel Microbiome Therapeutics Basic Information
Table 142. Osel Microbiome Therapeutics Product Overview
Table 143. Osel Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Osel Business Overview
Table 145. Osel Recent Developments
Table 146. Metabogen Microbiome Therapeutics Basic Information
Table 147. Metabogen Microbiome Therapeutics Product Overview
Table 148. Metabogen Microbiome Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Metabogen Business Overview
Table 150. Metabogen Recent Developments
Table 151. Global Microbiome Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 152. Global Microbiome Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 153. North America Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 154. North America Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 155. Europe Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 156. Europe Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 157. Asia Pacific Microbiome Therapeutics Sales Forecast by Region (2025-2030) & (K Units)
Table 158. Asia Pacific Microbiome Therapeutics Market Size Forecast by Region (2025-2030) & (M USD)
Table 159. South America Microbiome Therapeutics Sales Forecast by Country (2025-2030) & (K Units)
Table 160. South America Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 161. Middle East and Africa Microbiome Therapeutics Consumption Forecast by Country (2025-2030) & (Units)
Table 162. Middle East and Africa Microbiome Therapeutics Market Size Forecast by Country (2025-2030) & (M USD)
Table 163. Global Microbiome Therapeutics Sales Forecast by Type (2025-2030) & (K Units)
Table 164. Global Microbiome Therapeutics Market Size Forecast by Type (2025-2030) & (M USD)
Table 165. Global Microbiome Therapeutics Price Forecast by Type (2025-2030) & (USD/Unit)
Table 166. Global Microbiome Therapeutics Sales (K Units) Forecast by Application (2025-2030)
Table 167. Global Microbiome Therapeutics Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Microbiome Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Microbiome Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Microbiome Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Microbiome Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Microbiome Therapeutics Market Size by Country (M USD)
Figure 11. Microbiome Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Microbiome Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Microbiome Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Microbiome Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Microbiome Therapeutics Market Share by Type
Figure 18. Sales Market Share of Microbiome Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Microbiome Therapeutics by Type in 2023
Figure 20. Market Size Share of Microbiome Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Microbiome Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Microbiome Therapeutics Market Share by Application
Figure 24. Global Microbiome Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Microbiome Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Microbiome Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Microbiome Therapeutics Market Share by Application in 2023
Figure 28. Global Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Microbiome Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Microbiome Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Microbiome Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Microbiome Therapeutics Sales Market Share by Region in 2023
Figure 44. China Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Microbiome Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Microbiome Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Microbiome Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Microbiome Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Microbiome Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Microbiome Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Microbiome Therapeutics Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Microbiome Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Microbiome Therapeutics Market Size (M USD), 2019-2030
Figure 5. Global Microbiome Therapeutics Market Size (M USD) (2019-2030)
Figure 6. Global Microbiome Therapeutics Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Microbiome Therapeutics Market Size by Country (M USD)
Figure 11. Microbiome Therapeutics Sales Share by Manufacturers in 2023
Figure 12. Global Microbiome Therapeutics Revenue Share by Manufacturers in 2023
Figure 13. Microbiome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Microbiome Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Microbiome Therapeutics Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Microbiome Therapeutics Market Share by Type
Figure 18. Sales Market Share of Microbiome Therapeutics by Type (2019-2024)
Figure 19. Sales Market Share of Microbiome Therapeutics by Type in 2023
Figure 20. Market Size Share of Microbiome Therapeutics by Type (2019-2024)
Figure 21. Market Size Market Share of Microbiome Therapeutics by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Microbiome Therapeutics Market Share by Application
Figure 24. Global Microbiome Therapeutics Sales Market Share by Application (2019-2024)
Figure 25. Global Microbiome Therapeutics Sales Market Share by Application in 2023
Figure 26. Global Microbiome Therapeutics Market Share by Application (2019-2024)
Figure 27. Global Microbiome Therapeutics Market Share by Application in 2023
Figure 28. Global Microbiome Therapeutics Sales Growth Rate by Application (2019-2024)
Figure 29. Global Microbiome Therapeutics Sales Market Share by Region (2019-2024)
Figure 30. North America Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 32. U.S. Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Microbiome Therapeutics Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Microbiome Therapeutics Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 37. Germany Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Microbiome Therapeutics Sales Market Share by Region in 2023
Figure 44. China Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 50. South America Microbiome Therapeutics Sales Market Share by Country in 2023
Figure 51. Brazil Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Microbiome Therapeutics Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Microbiome Therapeutics Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Microbiome Therapeutics Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Microbiome Therapeutics Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Microbiome Therapeutics Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Microbiome Therapeutics Market Share Forecast by Type (2025-2030)
Figure 65. Global Microbiome Therapeutics Sales Forecast by Application (2025-2030)
Figure 66. Global Microbiome Therapeutics Market Share Forecast by Application (2025-2030)
